United Therapeutics to build $500M manufacturing facility in RTP

Published June 30, 2023

“A multibillion-dollar company is growing its footprint in Research Triangle Park with plans for a $500 million manufacturing facility.

United Therapeutics (Nasdaq: UTHR) is building the facility to expand its capacity to produce a drug-device combination product that received approval by the U.S. Food and Drug Administration last year. The product, Tyvaso DPI, is a central part of the company’s growth strategy as it aims to double its revenue in the coming years.”

Read more at the Triangle Business Journal (subscribers only)

United Therapeutics Logo
(PRNewsfoto/United Therapeutics Corporation)